Northwestern University led new work toward implantable “living pharmacies,” reporting a wireless hybrid oxygenation platform (HOBIT) that supports engineered cells producing multiple therapeutics in vivo. In a rat model, the team integrated oxygen-generating bioelectronics with cell therapies engineered to produce three biologics simultaneously, aiming to overcome the oxygen-limitation barrier that has constrained implantable cell output.